|
G |
Alb |
albumin |
affects binding |
ISO |
Halothane binds to ALB protein |
CTD |
PMID:17242087 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
[Ryanodine co-treated with Halothane] results in increased expression of BAX mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of BAX mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions increases expression |
ISO |
[Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of BCL2L11 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Calr |
calreticulin |
affects metabolic processing |
EXP |
Halothane metabolite affects the metabolism of CALR |
CTD |
PMID:1504264 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
Halothane results in decreased expression of CCL2 mRNA |
CTD |
PMID:15564938 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd69 |
Cd69 molecule |
increases expression |
ISO |
Halothane results in increased expression of CD69 protein |
CTD |
PMID:21245496 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
decreases expression |
EXP |
Halothane results in decreased expression of CXCL1 mRNA |
CTD |
PMID:15564938 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression |
EXP |
Halothane results in decreased expression of CXCL10 mRNA |
CTD |
PMID:15564938 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression decreases expression multiple interactions |
EXP ISO |
Halothane results in increased expression of CXCL2 mRNA Halothane results in decreased expression of CXCL2 mRNA Halothane results in increased expression of CXCL2 mRNA; Halothane results in increased expression of CXCL2 protein [Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA; [Progesterone co-treated with Halothane] results in increased expression of CXCL2 protein; Dantrolene inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]; Estradiol inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]; Fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]]; gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA]; Mifepristone inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA] |
CTD |
PMID:10422944 PMID:15564938 PMID:19633216 PMID:21501669 PMID:22157104 PMID:24598351 PMID:24747151 PMID:32795494 More...
|
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of CXCL1 mRNA; Halothane results in increased expression of CXCL1 protein Estradiol inhibits the reaction [Halothane results in increased expression of CXCL1 mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of CXCL1 mRNA]]; gadolinium chloride inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; Mifepristone inhibits the reaction [Halothane results in increased expression of CXCL1 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]; U 0126 inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]] |
CTD |
PMID:21501669 PMID:22157104 PMID:24598351 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions increases metabolic processing |
ISO |
diisopropyl 1,3-dithiol-2-ylidenemalonate results in increased expression of [CYB5A protein results in increased metabolism of Halothane] |
CTD |
PMID:3689822 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases metabolic processing |
ISO |
CYP2B6 protein results in increased metabolism of Halothane |
CTD |
PMID:11684365 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases metabolic processing affects metabolic processing increases oxidation multiple interactions increases response to substance |
ISO EXP |
CYP2E1 protein results in increased metabolism of Halothane CYP2E1 protein affects the metabolism of Halothane CYP2E1 protein results in increased oxidation of Halothane Disulfiram inhibits the reaction [CYP2E1 protein results in increased oxidation of Halothane] CYP2E1 protein results in increased susceptibility to Halothane |
CTD |
PMID:9103523 PMID:10805064 PMID:11684365 PMID:12464242 PMID:12803597 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing |
ISO |
CYP3A4 protein results in increased metabolism of Halothane |
CTD |
PMID:8886607 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of DDIT3 mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of DDIT3 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of DDIT3 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of FKBP1A mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of FKBP1A mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of FKBP1A mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
multiple interactions increases expression |
ISO |
[Ryanodine co-treated with Halothane] results in increased expression of FKBP1B mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of FKBP1B mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Halothane results in increased expression of FOS protein |
CTD |
PMID:7970238 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of GPT protein Dantrolene inhibits the reaction [Halothane results in increased expression of GPT protein]; eritoran inhibits the reaction [Halothane results in increased expression of GPT protein]; Ryanodine promotes the reaction [Halothane results in increased expression of GPT protein] |
CTD |
PMID:24598351 PMID:24747151 PMID:32795494 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hmgb1 |
high mobility group box 1 |
increases expression |
ISO |
Halothane results in increased expression of HMGB1 protein |
CTD |
PMID:21245496 PMID:24747151 |
|
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of HMOX1 mRNA [Ryanodine co-treated with Halothane] results in increased expression of HMOX1 mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of HMOX1 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Homer1 |
homer scaffold protein 1 |
multiple interactions increases expression |
ISO |
Dantrolene inhibits the reaction [Halothane results in increased expression of HOMER1 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of HOMER1 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression multiple interactions increases expression |
EXP ISO |
Halothane results in decreased expression of ICAM1 mRNA; Halothane results in decreased expression of ICAM1 protein [Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA; [U 0126 co-treated with Halothane] results in increased expression of ICAM1 mRNA; Estradiol inhibits the reaction [Halothane results in increased expression of ICAM1 mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of ICAM1 mRNA]]; gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA]; Mifepristone inhibits the reaction [Halothane results in increased expression of ICAM1 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of ICAM1 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of ICAM1 mRNA]; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA] |
CTD |
PMID:15564938 PMID:21501669 PMID:22157104 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions increases expression increases response to substance |
ISO EXP |
PRF1 protein affects the reaction [Halothane results in increased expression of IFNG protein]; TLR4 protein affects the reaction [Halothane results in increased expression of IFNG protein] Halothane results in increased expression of IFNG mRNA IFNG protein results in increased susceptibility to Halothane |
CTD |
PMID:10422944 PMID:21245496 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il17a |
interleukin 17A |
multiple interactions increases expression |
ISO |
Estradiol inhibits the reaction [Halothane results in increased expression of IL17A protein]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of IL17A protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL17A protein]]; Progesterone promotes the reaction [Halothane results in increased expression of IL17A protein] |
CTD |
PMID:19633216 PMID:21501669 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
EXP ISO |
Halothane affects the reaction [IL1B protein affects the susceptibility to Phenylephrine]; Halothane affects the reaction [IL1B protein affects the susceptibility to Potassium Chloride]; Halothane inhibits the reaction [IL1B protein results in increased abundance of Cyclic GMP]; Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 protein]; Halothane inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] Halothane results in increased expression of IL1B mRNA [Ryanodine co-treated with Halothane] results in increased expression of IL1B mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of IL1B mRNA]; Estradiol inhibits the reaction [Halothane results in increased expression of IL1B mRNA]; Fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of IL1B mRNA]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL1B mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of IL1B mRNA] |
CTD |
PMID:10422944 PMID:11506125 PMID:21501669 PMID:24747151 PMID:32795494 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of IL6 mRNA Estradiol inhibits the reaction [Halothane results in increased expression of IL6 mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of IL6 mRNA]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL6 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of IL6 mRNA] |
CTD |
PMID:21501669 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of ITGAM mRNA Ryanodine promotes the reaction [Halothane results in increased expression of ITGAM mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 1:182,659,047...182,709,495
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
increases expression |
ISO |
Halothane results in increased expression of ITPR1 mRNA |
CTD |
PMID:32795494 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
increases expression |
ISO |
Halothane results in increased expression of ITPR3 mRNA |
CTD |
PMID:32795494 |
|
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
affects response to substance |
ISO |
KCNJ2 affects the susceptibility to Halothane |
CTD |
PMID:17546530 |
|
NCBI chr10:96,060,849...96,071,401
Ensembl chr10:96,060,821...96,071,445
|
|
G |
Kcnk10 |
potassium two pore domain channel subfamily K member 10 |
multiple interactions |
ISO |
Halothane promotes the reaction [KCNK10 protein results in increased transport of Potassium] |
CTD |
PMID:16075240 |
|
NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695
|
|
G |
Kcnk2 |
potassium two pore domain channel subfamily K member 2 |
multiple interactions |
ISO |
Halothane promotes the reaction [KCNK2 protein results in increased transport of Potassium] |
CTD |
PMID:16075240 |
|
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
|
|
G |
Kcnk9 |
potassium two pore domain channel subfamily K member 9 |
multiple interactions |
ISO |
Halothane promotes the reaction [KCNK9 protein results in increased transport of Potassium] |
CTD |
PMID:11249964 |
|
NCBI chr 7:104,429,186...104,473,924
Ensembl chr 7:104,437,934...104,473,175
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK1 protein; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:22157104 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases expression decreases expression |
ISO |
Halothane results in increased expression of MAPK14 mRNA Halothane results in decreased expression of MAPK14 protein |
CTD |
PMID:24598351 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK3 protein; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:22157104 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mir106b |
microRNA 106b |
decreases expression |
ISO |
Halothane results in decreased expression of MIR106B mRNA |
CTD |
PMID:24598351 |
|
NCBI chr12:17,043,344...17,043,425
Ensembl chr12:17,043,344...17,043,425
|
|
G |
Mir21 |
microRNA 21 |
affects expression |
ISO |
Halothane affects the expression of MIR21A mRNA |
CTD |
PMID:24598351 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mpo |
myeloperoxidase |
decreases activity |
EXP |
Halothane results in decreased activity of MPO protein |
CTD |
PMID:15564938 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases phosphorylation multiple interactions |
EXP |
Halothane results in increased phosphorylation of NFKBIA protein Propofol inhibits the reaction [Halothane results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:16965849 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP |
Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 protein]; Propofol inhibits the reaction [Halothane results in increased expression of NOS2 protein] |
CTD |
PMID:11506125 PMID:16965849 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Pomc |
proopiomelanocortin |
increases secretion |
EXP |
Halothane results in increased secretion of POMC protein |
CTD |
PMID:2846107 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Prf1 |
perforin 1 |
affects response to substance multiple interactions |
ISO |
PRF1 protein affects the susceptibility to Halothane PRF1 protein affects the reaction [Halothane results in increased expression of IFNG protein] |
CTD |
PMID:21245496 |
|
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
Halothane inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] |
CTD |
PMID:11506125 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
ISO |
Halothane results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:18215454 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ren |
renin |
multiple interactions |
ISO |
[Halothane co-treated with Nitroprusside] results in increased activity of REN protein |
CTD |
PMID:3281763 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Ryr1 |
ryanodine receptor 1 |
increases activity multiple interactions increases response to substance increases expression |
ISO |
Halothane results in increased activity of RYR1 protein [Halothane results in increased activity of RYR1 protein] which affects the localization of Calcium RYR1 protein mutant form results in increased susceptibility to Halothane Halothane results in increased expression of RYR1 mRNA |
CTD |
PMID:14641996 PMID:15210166 PMID:21485675 PMID:32795494 |
|
NCBI chr 1:84,292,578...84,423,799
Ensembl chr 1:84,292,578...84,423,812
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of S100A8 mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of S100A8 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of S100A8 mRNA] |
CTD |
PMID:24747151 PMID:28138970 PMID:32795494 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of S100A9 mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of S100A9 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of S100A9 mRNA] |
CTD |
PMID:24747151 PMID:32795494 |
|
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions increases expression |
ISO |
Halothane results in increased expression of and results in increased phosphorylation of STAT3 protein Halothane results in increased expression of STAT3 mRNA |
CTD |
PMID:24598351 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
TLR4 protein affects the reaction [Halothane results in increased expression of IFNG protein] |
CTD |
PMID:21245496 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
increases expression decreases expression multiple interactions |
EXP ISO |
Halothane results in increased expression of TNF mRNA Halothane results in decreased expression of TNF mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of TNF mRNA]; Estradiol inhibits the reaction [Halothane results in increased expression of TNF mRNA]; Fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of TNF mRNA]]; Mifepristone inhibits the reaction [Halothane results in increased expression of TNF mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of TNF mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of TNF mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of TNF mRNA] |
CTD |
PMID:10422944 PMID:15564938 PMID:21501669 PMID:22157104 PMID:24598351 PMID:32795494 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions increases expression |
ISO |
Dantrolene inhibits the reaction [Halothane results in increased expression of VCAM1 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of VCAM1 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|